Movement Alert｜10x Genomics, Inc. Falls 5.45% in Regular Trading, Life Sciences Tools and Services Sector Under Broad Pressure

Market Focus07-31

On July 31, 10x Genomics, Inc. fell 5.45% in regular trading, at $46.71/share, with turnover of $30.859 million. The decline came amid broad-based selling pressure across the Life Sciences Tools and Services sector, with multiple peer names posting notable losses in the same session.

Among sector peers, Illumina fell 5.4%, Thermo Fisher Scientific fell 2.08%, Tempus AI fell 2.53%, and Danaher fell 1.64%, while Bio-Techne was essentially flat at +0.06%. The sector-wide weakness dragged 10x Genomics lower despite a constructive fundamental backdrop heading into its August 6 earnings report, for which consensus expects revenue of approximately $147 million (up 5.28% year-over-year) and adjusted EPS of -$0.24. Earlier in July, BofA Securities had raised its price target on the stock from $30 to $46, and the company recently announced collaborations with Lausanne University Hospital and Cleveland Clinic to advance single-cell and spatial technologies in cancer diagnostics.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1116153123?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-31 23:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1116153123","market":"hk","top_or_hot":-1,"title":"Movement Alert｜10x Genomics, Inc. Falls 5.45% in Regular Trading, Life Sciences Tools and Services Sector Under Broad Pressure","media":"Market Focus","content":"<p><p>On July 31, 10x Genomics, Inc. fell 5.45% in regular trading, at $46.71/share, with turnover of $30.859 million. The decline came amid broad-based selling pressure across the Life Sciences Tools and Services sector, with multiple peer names posting notable losses in the same session.</p><p>Among sector peers, Illumina fell 5.4%, Thermo Fisher Scientific fell 2.08%, Tempus AI fell 2.53%, and Danaher fell 1.64%, while Bio-Techne was essentially flat at +0.06%. The sector-wide weakness dragged 10x Genomics lower despite a constructive fundamental backdrop heading into its August 6 earnings report, for which consensus expects revenue of approximately $147 million (up 5.28% year-over-year) and adjusted EPS of -$0.24. Earlier in July, BofA Securities had raised its price target on the stock from $30 to $46, and the company recently announced collaborations with Lausanne University Hospital and Cleveland Clinic to advance single-cell and spatial technologies in cancer diagnostics.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜10x Genomics, Inc. Falls 5.45% in Regular Trading, Life Sciences Tools and Services Sector Under Broad Pressure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜10x Genomics, Inc. Falls 5.45% in Regular Trading, Life Sciences Tools and Services Sector Under Broad Pressure\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-31 23:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 31, 10x Genomics, Inc. fell 5.45% in regular trading, at $46.71/share, with turnover of $30.859 million. The decline came amid broad-based selling pressure across the Life Sciences Tools and Services sector, with multiple peer names posting notable losses in the same session.</p><p>Among sector peers, Illumina fell 5.4%, Thermo Fisher Scientific fell 2.08%, Tempus AI fell 2.53%, and Danaher fell 1.64%, while Bio-Techne was essentially flat at +0.06%. The sector-wide weakness dragged 10x Genomics lower despite a constructive fundamental backdrop heading into its August 6 earnings report, for which consensus expects revenue of approximately $147 million (up 5.28% year-over-year) and adjusted EPS of -$0.24. Earlier in July, BofA Securities had raised its price target on the stock from $30 to $46, and the company recently announced collaborations with Lausanne University Hospital and Cleveland Clinic to advance single-cell and spatial technologies in cancer diagnostics.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TXG","symbol_name":"10x Genomics, Inc.","start_time":0,"source_url":"","article_id":"1116153123","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1116153123","pubTimestamp":1785510627,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 31, 10x Genomics, Inc. fell 5.45% in regular trading, at $46.71/share, with turnover of $30.859 million. The decline came amid broad-based selling pressure across the Life Sciences Tools and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TXG":"10x Genomics, Inc."},"translate_title":"走势警报|10x Genomics, Inc. 常规交易下跌 5.45%，生命科学工具和服务板块面临广泛压力","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TXG":1},"content_text":"On July 31, 10x Genomics, Inc. fell 5.45% in regular trading, at $46.71/share, with turnover of $30.859 million. The decline came amid broad-based selling pressure across the Life Sciences Tools and Services sector, with multiple peer names posting notable losses in the same session.Among sector peers, Illumina fell 5.4%, Thermo Fisher Scientific fell 2.08%, Tempus AI fell 2.53%, and Danaher fell 1.64%, while Bio-Techne was essentially flat at +0.06%. The sector-wide weakness dragged 10x Genomics lower despite a constructive fundamental backdrop heading into its August 6 earnings report, for which consensus expects revenue of approximately $147 million (up 5.28% year-over-year) and adjusted EPS of -$0.24. Earlier in July, BofA Securities had raised its price target on the stock from $30 to $46, and the company recently announced collaborations with Lausanne University Hospital and Cleveland Clinic to advance single-cell and spatial technologies in cancer diagnostics.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1116153123","isCrawlerRequest":true}